Study of High Sensitive C-Reactive Protein (HS-CRP) After Cardiac Rehabilitation Program in Patients Undergoing

Adel Johari Moghadam1, Saied Azizinejad1

  • 1Department of Cardiology, AJA University of Medical Sciences, Tehran, Iran.

Insights

Cardiac rehabilitation significantly reduces high-sensitivity C-reactive protein (hs-CRP) levels in patients post-coronary artery bypass surgery. This 8-week program effectively lowers inflammation markers, indicating reduced cardiovascular risk.

Area of Science:

  • Cardiology
  • Biochemistry
  • Preventive Medicine

Background:

  • Cardiac rehabilitation is recognized for reducing cardiovascular complications.
  • The impact of cardiac rehabilitation on high-sensitivity C-reactive protein (hs-CRP), a key inflammation and cardiovascular risk marker, requires further investigation.

Purpose of the Study:

  • To investigate the effect of an 8-week conventional cardiac rehabilitation program on hs-CRP levels.
  • To assess hs-CRP changes in patients who underwent isolated coronary artery bypass surgery (CABGS).

Main Methods:

  • A case study involving 30 patients undergoing isolated CABGS who completed an 8-week cardiac rehabilitation program.
  • A control group of 30 similar patients not participating in the rehabilitation program.
  • Retrospective measurement of serum hs-CRP levels before and after the 8-week intervention period.

Main Results:

  • Initial hs-CRP levels were comparable between the rehabilitation and control groups (P=0.833).
  • After the 8-week program, hs-CRP levels significantly decreased in the rehabilitation group (2.3 ± 5.1) compared to the control group (5.7 ± 6.1) (P=0.023).
  • The reduction in hs-CRP was statistically significant in the rehabilitation group (P=0.037) but not in the control group (P=0.0723).

Conclusions:

  • An 8-week cardiac rehabilitation program significantly reduces hs-CRP levels in patients post-coronary artery bypass surgery.
  • Cardiac rehabilitation effectively lowers inflammation markers, contributing to reduced cardiovascular risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
670
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
355
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
360
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K